Nav: Home

MDI Biological Laboratory providing incubator space to Coagulation Sciences LLC

January 25, 2017

BAR HARBOR, MAINE -- The MDI Biological Laboratory has announced that it is providing incubator space and associated scientific resources on its Bar Harbor campus to Coagulation Sciences LLC a Riverdale, N.Y- based development-stage medical device company.

Coagulation Sciences is developing the Multiple Coagulation Test System (MCTSTM) to help hospitals minimize or eliminate unnecessary blood transfusions and their associated risks by providing information to physicians to arrest bleeding more rapidly.

Michael Kagan, Coagulation Sciences' director of product development, an engineer and Maine resident, hopes to establish manufacturing of the MCTSTM instrument and its disposable test cartridge in Maine. Kagan chose the incubator space at the MDI Biological Laboratory because of its location and the institution's commitment to developing a vibrant life sciences ecosystem in Maine.

"Maine needs to develop a support system to promote innovation and commercialization if it is going to grow its life sciences sector," Kagan said. "An important step is providing the incubator space and expertise to move a product through its development cycle. The MDI Biological Laboratory has the core laboratory facilities, infrastructure and access to expertise that will help us take Coagulation Sciences to the next level. This space allows us to expand our development efforts without additional capital equipment."

Coagulation Sciences is representative of the trend toward personalized medicine, or the tailoring of treatments to individual needs. Current tests to determine if transfusions are needed are often non-specific or too slow to inform transfusion decisions. As a result, 30 to 40 percent of blood transfusions are unnecessary. The company's automated analytical system will have the ability to determine within minutes if a coagulation disorder is truly present, and, if so, help define the nature of the problem so that the physician can make an informed decision regarding treatment.

The MDI Biological Laboratory is an independent nonprofit biomedical research institution focused on basic discovery, translation of discoveries into technologies that improve human health and driving innovation and entrepreneurship through interdisciplinary research, training and network-building. The institution's research and development activities are focused on regenerative medicine and its scientists are pioneering new approaches to treating devastating diseases like heart attack.

"Our goal is to help create an entrepreneurial ecosystem that nurtures innovation in the life sciences by providing a collaborative environment and by connecting entrepreneurs with the resources they need," said Kevin Strange, Ph.D., MDI Biological Laboratory president. "Coagulation Sciences has developed a new technology that will revolutionize the way we manage blood transfusions and is seeking to manufacture its device in Maine. This is exactly the type of company we want to help support."

Other innovative startups that the MDI Biological Laboratory has helped to launch and/or grow include RockStep Solutions, a life sciences-based software development startup; Anecdata, a data collection web application for crowd sourcing scientific and other types of data; and Novo Biosciences, the institution's first for-profit spin-off, which is developing drug therapies to reactivate and stimulate the body's innate healing abilities.

"Maine's enviable quality of life, Yankee work ethic and outstanding research and educational institutions can be leveraged to build a thriving life sciences industry sector," Kagan says. "But continued investment in the infrastructure and resources to attract and support new life sciences enterprises and the development of a technology-focused entrepreneurial culture is critical."
The MDI Biological Laboratory, located in Bar Harbor, Maine, is an independent, non-profit biomedical research institution focused on increasing healthy lifespan and increasing our natural ability to repair and regenerate tissues damaged by injury or disease. The institution develops solutions to complex human health problems through research, education and ventures that transform discoveries into cures. For more information, please visit

Mount Desert Island Biological Laboratory

Related Blood Transfusions Articles:

Giving trauma patients blood pressure stabilizing hormone cuts transfusions by half
Giving trauma patients with severe blood loss the hormone arginine vasopressin (AVP) cut the volume of blood products required to stabilize them by half, according to results of a new, first-of-its-kind clinical trial from Penn Medicine.
Of mice and babies: New mouse model links transfusions to deadly infant digestive disease
Physicians have long suspected that red blood cell transfusions given to premature infants with anemia may put them in danger of developing a potentially lethal inflammatory disease of the intestines.
Postpartum transfusions on the rise, carry greater risk of adverse events
Women who receive a blood transfusion after giving birth are twice as likely to have an adverse reaction related to the procedure, such as fever, respiratory distress, or hemolysis (destruction of red blood cells), compared with non-pregnant women receiving the same care, according to a new study published today in Blood Advances.
Impeding white blood cells in antiphospholipid syndrome reduced blood clots
A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.
Transfusions with older blood linked to adverse events, death, new study finds
Major trauma victims who receive transfusions of packed blood 22 days old or older may face increased risk of death within 24 hours, according to a new study in Annals of Emergency Medicine.
More Blood Transfusions News and Blood Transfusions Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...